Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Interviews as Topic × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Hematopoietic and Lymphatic System Neoplasm 9 Neoplasms 8 Prostatic Neoplasms 6 Lung Neoplasms 6 Colorectal Neoplasms 5 Ovarian Neoplasms 4 Malignant Solid Neoplasm 4 Hematologic Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Incontinence 1 Thyroid Cancer, Papillary 1 Testicular Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Obesity-Related Malignant Neoplasm 1 Neuroblastoma 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Mouth Neoplasms 1

Interventions

Cyclophosphamide 17 Rituximab 16 fludarabine 11 pirtobrutinib 8 Specimen Handling 8 Magnetic Resonance Spectroscopy 7 venetoclax 5 polatuzumab vedotin 5 obinutuzumab 5 glofitamab 5 Vincristine 5 Doxorubicin 5 zanubrutinib 4 Prednisone 4 Dexamethasone 4 Biopsy 4 tazemetostat 3 tafasitamab 3 pembrolizumab 3 fludarabine phosphate 3 acalabrutinib 3 Nivolumab 3 Leukapheresis 3 Etoposide 3 Bendamustine Hydrochloride 3 pomalidomide 2 loncastuximab tesirine 2 ibrutinib 2 etoposide phosphate 2 cemiplimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡